Molecular biology studies showed that TRIM3 promoted P53 degradation and suppressed P53 target gene expression, which ultimately promoted cancer cell growth and inhibited cisplatin-induced apoptosis in P53 wild type breast cancer cells. Here, TP53 is linked to cancer.